Remembering Dr. Craig Leonardi
The International Psoriasis Council (IPC) remembers Dr. Craig Leonardi, founding member and former President, whose research shaped modern psoriasis treatment.
The IPC Rapid Communications initiative aims to deliver concise, expert perspectives on emerging developments in psoriasis research, clinical practice, and health policy. Each publication highlights urgent or important issues where swift dissemination of expert insights can inform and improve patient care worldwide.
New discoveries, therapies, and data in psoriasis care evolve quickly—and clinicians need access to expert interpretation as soon as possible.
Rapid Communications allow IPC experts to respond to new evidence or pressing issues in real time, bridging the gap between guideline updates and helping practitioners stay current with global best practices.
Each Rapid Communication is a short, focused publication, typically under 500 words with up to five references, developed by IPC experts. Up to four are released annually and may take the form of expert commentaries, white papers, or position statements.
Selected manuscripts are fast-tracked for publication in peer-reviewed journals or shared on the IPC website to ensure timely global access.
Ideas are solicited annually from IPC members, Corporate Partners, and patient partner organizations. Submissions are evaluated by the IPC Editorial Committee based on:
Authors are chosen from among those who proposed the idea with attention to expertise and geographic diversity. While IPC aims to include idea contributors whenever possible, participation as an author is not guaranteed. Each manuscript undergoes a structured review and approval by the IPC Board of Directors before publication.
Stay up to date with the newest expert commentaries shaping psoriasis care.
Management of Moderate-to-Severe Psoriasis in Patients with Cancer: Guidance from the International Psoriasis Council. Gisondi P, Carrascosa JM, Jo SJ, et al. JAAD Reviews. Published online August 14, 2026. doi.org/10.1016/j.jdrv.2026.08.004.
Bridging Psoriasis and Metabolic Comorbidities: Toward Comprehensive Patient Management. Priorities from the International Psoriasis Council. Strober BE, Treichel AM, Bowcock AM, et al. J Am Acad Dermatol. Published online July 25, 2026. doi:10.1016/j.jaad.2026.07.066
International Psoriasis Council Psoriasis Disease Severity Reclassification: Update on Validity, Acceptance, and Implementation. Strober BE, Blauvelt A, van de Kerkhof PC, et al. J Am Acad Dermatol. 2025 Oct;93(4):1154-1157. doi: 10.1016/j.jaad.2025.05.1445. Epub 2025 Jun 6. PMID: 40484137.
These key clinical topics are under active development for upcoming Rapid Communication publications.
We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
The International Psoriasis Council (IPC) remembers Dr. Craig Leonardi, founding member and former President, whose research shaped modern psoriasis treatment.
IPC Councilor José-Manuel Carrascosa Carrillo, MD, PhD, on the BeNeBio trial and whether dose reduction fits an era focused on disease modification.
What happened in psoriasis at the 2026 EADV Congress? IPC shares highlights from its symposium on personalized medicine, as well as psoriasis sessions and late-breaking research from Vienna.
World Psoriasis Day, observed each year on October 29, was launched by the International Federation of Psoriasis Associations (IFPA) in 2004 to give a voice to the more than 125 million people worldwide living with psoriasis and psoriatic arthritis. To mark this year’s observance, IPC joined the Latin American Society of Psoriasis and Dermoimmunology (SOLAPSO) and the Skin Inflammation and Psoriasis International Network (SPIN) to create a video series around the theme “Look Beyond My Skin,” featuring voices from all three organizations. Missed the videos on social media? Watch the full series on the IPC YouTube channel.
Take Two with IPC gives a longer presentation a second life in two minutes. Each video takes an expert talk IPC has already published (a Take Ten recording or a symposium presentation) and condenses the clinical substance. The series launched this month alongside the World Psoriasis Day campaign with four videos on pediatric psoriasis: Psoriasis Look-Alikes and Anti-TNF-α Induced Skin Eruptions with IPC Board Member Amy Paller, MS, MD; Conventional Therapies with IPC Councilor Mona El-Kalioby, MBBCh, MSc, MD; and Phototherapy in Pediatric Psoriasis with Fernando Valenzuela, MD. New Take Two videos will be featured each month, drawn from the Take Ten with IPC library and recordings from IPC symposia, with a link to the full presentation for each.
Select presentations from the Eczema and Psoriasis Research Incubator: Cross-Disciplinary Innovation Forum, hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the 55th Annual European Society for Dermatological Research (ESDR) Meeting, are now available. Topics include disease endotypes, atopic dermatitis-psoriasis overlap, cardiovascular risk in psoriasis, and genetic susceptibility.
In this Take Ten with IPC video, Juul van den Reek and PhD candidate Liana Barenbrug discuss sex differences in psoriasis, why these distinctions matter, what current research tells us, and which areas should be prioritized in future psoriasis research.